The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria.

Castello, Angelo; Castellani, Massimo; Florimonte, Luigia; Urso, Luca; Mansi, Luigi; Lopci, Egesta

Castello, Angelo; Castellani, Massimo; Florimonte, Luigia; Urso, Luca; Mansi, Luigi; Lopci, Egesta.

Afiliação

Castello A; Nuclear Medicine Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Castellani M; Nuclear Medicine Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Florimonte L; Nuclear Medicine Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Urso L; Nuclear Medicine Unit, Oncological Medical and Specialist Department, University Hospital of Ferrara, 44121 Ferrara, Italy.
Mansi L; Interuniversity Research Center for the Sustainable Development (CIRPS), 00152 Rome, Italy.
Lopci E; Nuclear Medicine Unit, IRCCS-Humanitas Research Hospital, 20089 Rozzano, Italy.

J Clin Med ; 11(6)2022 Mar 21.

Article em En | MEDLINE | ID: mdl-35330068

Palavras-chave

PET/CT; deep learning; immune checkpoint inhibitors; lung cancer; radiomics; response assessment; survival; texture analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google